06/04/2024 1:55 PM | Merck & Co., Inc. (Issuer) Rothman Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:59 PM | Merck & Co., Inc. (Issuer) Warden Kathy J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 2:00 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 2:02 PM | Merck & Co., Inc. (Issuer) RUSSO PATRICIA F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:41 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:44 PM | BAKER DOUGLAS M JR (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:44 PM | Merck & Co., Inc. (Issuer) THULIN INGE G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/04/2024 1:32 PM | Mayo Stephen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:34 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:38 PM | Craig Pamela J. (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:15 PM | LAVIZZO-MOUREY RISA J (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:39 PM | Merck & Co., Inc. (Filer)
| Form CERT | |
05/20/2024 5:28 AM | Merck & Co., Inc. (Filer) MSD Netherlands Capital B.V. (Filer)
| Form 424B5 | |
05/15/2024 10:31 AM | Merck & Co., Inc. (Filer) MSD Netherlands Capital B.V. (Filer)
| Form POSASR | |
05/06/2024 3:29 PM | Merck & Co., Inc. (Subject) MIZELL STEVEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 3:15 PM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:17 PM | Li Dean Y (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:19 PM | Merck & Co., Inc. (Issuer) Zachary Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 5:41 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-K/A | |
04/11/2024 3:08 PM | Merck & Co., Inc. (Filer)
| Form DEF 14A | |
04/11/2024 3:10 PM | Merck & Co., Inc. (Filer)
| Form DEFA14A | |
04/11/2024 3:12 PM | Merck & Co., Inc. (Filer)
| Form ARS | |
04/08/2024 12:56 PM | Larson Betty D (Reporting) Merck & Co., Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/01/2024 4:16 PM | Inspire Investing, LLC (Filed by) Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/29/2024 3:12 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:14 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:16 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:18 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:57 PM | Bowyer Research, Inc. (Filed by) Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/11/2024 2:27 PM | Harpoon Therapeutics, Inc. (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:24 PM | Davis Robert M (Reporting) Merck & Co., Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 3:01 PM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:35 PM | Merck & Co., Inc. (Subject) Oosthuizen Johannes Jacobus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 5:39 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 2:29 PM | Evaxion Biotech A/S (Subject) Merck & Co., Inc. (Filed by)
| Form SC 13G | |
01/17/2024 4:52 PM | Harpoon Therapeutics, Inc. (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:27 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:18 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 4:27 PM | Merck & Co., Inc. (Issuer) Smart Dalton (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2023 6:36 AM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
It's time to ween off Chinese lithium! (Ad) As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution |
11/09/2023 8:04 AM | DeLuca Richard R. (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 2:49 PM | Downing Cristal N (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 10:08 AM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/26/2023 5:38 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 2:45 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 2:20 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 2:33 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 2:04 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:12 PM | Merck & Co., Inc. (Subject) MIZELL STEVEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023 5:46 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2023 3:53 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 3:36 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 3:21 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 1:09 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/27/2023 1:10 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/27/2023 1:11 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |